Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/efiTCfbwoceYrQsxzKwj

January 15, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
 Registration is now open for PCMA's Managed Markets Educational Forum!
Whether you are a seasoned managed markets executive or someone who supports the team, PCMA's Managed Markets Educational Forum will provide valuable education on fundamental, as well as complex and strategic issues relevant to professionals of all levels within pharma managed markets or market access divisions. Visit PCMA's website to learn more about our 2013 events!
 

  Legislative & Regulatory News 
  • HHS publishes Affordable Care Act regulations
    HHS released a 474-page document on Monday with proposed regulations regarding Medicaid expansion, state health insurance exchanges and other pieces of the Affordable Care Act. The draft covers the development of systems for helping people find out whether they are eligible for Medicaid or tax credits for health insurance, and for dealing with denials of Medicaid claims. The administration is seeking feedback on the draft. BenefitsPro.com (1/14) LinkedInFacebookTwitterEmail this Story
  • Remaining undecided states must soon commit to exchange plans
    New Hampshire and Florida are the only states that remain undecided on the implementation of a health insurance exchange. They have until Feb. 15 to commit to a partnership exchange with the federal government under the Affordable Care Act; otherwise, they will default to a federally run marketplace. The Washington Post (1/13) LinkedInFacebookTwitterEmail this Story
  • Other News
  Drug Industry Spotlight 
  • Drugmakers look for approval of potential blockbusters
    Drugmakers including Roche Holding, GlaxoSmithKline, Eli Lilly & Co., Biogen Idec, Gilead Sciences and Novo Nordisk are advancing drugs that could turn out to be blockbusters. But profits might be tempered as insurers and governments increasingly balk at paying high prices for new drugs, says PricewaterhouseCoopers' Simon Friend. Reuters (1/15) LinkedInFacebookTwitterEmail this Story
  • "Inappropriate marketing" tarnishes pharma's rep, survey finds
    The reputation of the pharmaceutical industry has tumbled, with 42% of 500 patient groups in 2011 giving the industry an "excellent" or "good" rating and just 34% of 600 patient groups doing so in 2012, per a Patient View survey. Further, half of those surveyed ranked the industry "poor" on fair pricing, and 40% said the reputation of the industry had declined. Patients offered myriad complaints, including "inappropriate marketing, a designation that included off-label marketing," writes Ed Silverman. Pharmalot.com/Pharma blog (1/14) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
If you can't write your idea on the back of my calling card, you don't have a clear idea."
--David Belasco,
American theatrical producer, director and playwright


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information